Anticoagulant Half-Life Of Heparin In Human Subjects With Normal And Impaired Renal Function.

Anticoagulant Half-Life Of Heparin In Human Subjects With Normal And Impaired Renal Function.

Bibliographic Details
Main Author:	Perry, Paul James
Published:	Scholarly Commons 1973
Subjects:	Pharmaceuticals Health and environmental sciences
Online Access:	https://scholarlycommons.pacific.edu/uop_etds/3301

Similar Items

HARNESSING TRANSTHYRETIN TO ENHANCE THE IN VIVO HALF-LIFE OF HUMAN INTERLEUKIN-2 (IL-2)
by: Liu, Fang
Published: (2021)

Heparins of enhanced anticoagulant activity
by: Denton, J.
Published: (1982)

Studies on the anticoagulant determinants of heparin /
by: Bergmann, Carl W.
Published: (1986)

Stability of Sildenafil in Combination with Heparin and Dopamine
by: Luu, Yao, et al.
Published: (2015)

The anticoagulant properties of unfractionated and fractionated heparins
by: MacGregor, I. R.
Published: (1980)

Monitoring Anticoagulation with Unfractionated Heparin on Renal Replacement Therapy. Which Is the Best aPTT Sampling Site?
by: Anton Florin Ioan, et al.
Published: (2020-08-01)

Spontaneous Breast Haematoma after Heparin Anticoagulation
by: Imran Yaseen Gani, et al.
Published: (2020-06-01)

Citrate Anticoagulation for CRRT in Children: Comparison with Heparin
by: Sara Nicole Fernández, et al.
Published: (2014-01-01)

Impaired renal function following intravascular contrast media : a pharmacological study of pathophysiological mediators
by: Oldroyd, Simon David
Published: (1997)

Oral Anticoagulants and Renal Impairment: The Convoluting Dilemma
by: Victor Serebruany
Published: (2016-06-01)

Characterization of AG10, a potent stabilizer of transthyretin, and its application in enhancing in vivo half-life of therapeutic peptides
by: Penchala, Sravan C.
Published: (2016)

Updates in Anticoagulation
by: Calhoun, McKenzie L.
Published: (2015)

Heparin and non-anticoagulant heparin attenuate histone-induced inflammatory responses in whole blood.
by: John Hogwood, et al.
Published: (2020-01-01)

Stability of Sildenafil in Combination with Heparin and Dopamine
by: Luu, Yao, et al.
Published: (2017)

State anxiety and memory performance : studies with anxiolytic drugs in normal subjects
by: Desai, Amee Nina
Published: (1982)

Pharmacokinetics and Pharmacodynamics of Ethanol in Healthy Volunteers: Effects of Input-Rate and Degree of Ethanol Exposure on Subjective and Objective Measures of Impairment
by: Ramchandani, Vijay A.
Published: (1996)

Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
by: V. O. Bitsadze, et al.
Published: (2021-07-01)

Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia
by: Maura Poli, et al.
Published: (2017-04-01)

An anticoagulant study of heparin and ticlopidine on hemodialy- sis in dogs
by: Tsai, A-Fang, et al.
Published: (1996)

Development of metal nanomaterials assists anticoagulant heparin biosensors
by: Wang, Shuo-Feng, et al.
Published: (2015)

Direct Oral Anticoagulants in Patients with Cancer
by: Bossaer, John B., et al.
Published: (2019)

Leukotriene and cytokine generation in atopic asthmatic, atopic non-asthmatic and normal subjects
by: Hood, Pauline Philippa
Published: (1998)

Development and evaluation of a population pharmacokinetic model for phenytoin in patients with impaired liver function
by: Hui, Tina Hsiao-Tin
Published: (1999)

The effects of prolonged anaesthesia on hepatic and renal functions
by: Murray, James M.
Published: (1993)

Laboratory control of anticoagulant therapy : an analysis of current dilemmas; heparin
by: Kitchen, S.
Published: (1998)

The disposition and pharmacokinetics of feprazone in human subjects
by: Berry, David John
Published: (1982)

Synthesis of AG10 analogs and optimization of TTR ligands for Half-life enhancement (TLHE) of Peptides
by: Jampala, Raghavendra
Published: (2017)

Heparin Anticoagulant for Human Bone Marrow Does Not Influence In Vitro Performance of Human Mesenchymal Stromal Cells
by: Yvonne Roger, et al.
Published: (2020-06-01)

Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants
by: Osamu Kumano, et al.
Published: (2021-03-01)

Pharmaceuticals in the Aquatic Environment: A Critical Appraisal of Uncertainty and Knowledge Gaps in Human Health Risk Assessment
by: Pokhrel, Lok R., et al.
Published: (2011)

Selected Pharmaceuticals in Different Aquatic Compartments: Part II—Toxicity and Environmental Risk Assessment
by: André Pereira, et al.
Published: (2020-04-01)

Selected Pharmaceuticals in Different Aquatic Compartments: Part I—Source, Fate and Occurrence
by: André Pereira, et al.
Published: (2020-02-01)

Investigation Of Physicochemical And Formulation Parameters For Transdermal Delivery Of Isoproterenol HC1
by: Patel, Rajesh Arvindkumar
Published: (1987)

The potential role of mitochondrial impairment in the pathogenesis of imatinib-induced renal injury
by: Ehsan Emadi, et al.
Published: (2019-06-01)

Synthetic, Sulfated, Lignin-Based Anticoagulants
by: Mehta, Akul
Published: (2014)

Potential Orally-Active Heparin-Like Compounds: Synthesis and Anticoagulant Activity
by: Ana Rita Conceição Neves
Published: (2019)

Periprocedural anticoagulation in transcatheter aortic valve replacement: Heparin vs bivalirudin
by: Abdul Mannan Khan Minhas, et al.
Published: (2017-01-01)

Potential Orally-Active Heparin-Like Compounds: Synthesis and Anticoagulant Activity
by: Ana Rita da Conceição Neves
Published: (2015)

The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19
by: Heloísa Antoniella Braz-de-Melo, et al.
Published: (2021-04-01)

Pharmacoeconomic evaluation of providing pharmacist-managed anticoagulation service to patients on warfarin
by: Stojković Tatjana, et al.
Published: (2016-01-01)